Unique ID issued by UMIN | UMIN000039610 |
---|---|
Receipt number | R000045172 |
Scientific Title | Verification study of anti-fatigue effect by ingestion of test beverage |
Date of disclosure of the study information | 2020/03/09 |
Last modified on | 2020/11/25 18:51:50 |
Verification study of anti-fatigue effect by ingestion of test beverage
Verification study of anti-fatigue effect by ingestion of test beverage
Verification study of anti-fatigue effect by ingestion of test beverage
Verification study of anti-fatigue effect by ingestion of test beverage
Japan |
N/A(healthy adults)
Not applicable |
Others
NO
To investigate the effect of test beverage ingestion on fatigue
Efficacy
Fatigue index using questionnaires after 2-week ingestion of test beverage
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Intake of test beverage for 2 weeks -> Washout for 2 weeks or more -> Intake of placebo beverage for 2 weeks
Intake of placebo beverage for 2 weeks -> Washout for 2 weeks or more -> Intake of test beverage for 2 weeks
50 | years-old | <= |
64 | years-old | >= |
Female
(1) Females aged between 50 and 64 years old who feel fatigue
(2) Subjects who have received sufficient explanation about the purpose and content of the study, have the ability to consent, voluntarily volunteered to participate, and agreed to participate it by signing the written informed consent
(1) Subjects who have history of diabetes, liver disease, kidney disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease
(2) Subjects who are judged by the principal investigator to have abnormal electrocardiogram
(3) Subjects who have injuries or illnesses that interfere with ergometer exercise
(4) Subjects who are under medical treatment
(5) Subjects who are allergic to food and drugs
(6) Subjects who cannot avoid taking health foods (including Food for Specified Health Uses, and Foods with Function Claims) and designated quasi-drugs during the test period
(7) Subjects who are taking medication (including OTC and prescription drugs)
(8) Subjects who have excessive alcohol consumption, or not avoid consumption of alcohol from the day before the test until the end of the test
(9) Subjects who are planning to get pregnant after the day of informed consent or are currently pregnant and lactating
(10) Subjects who have participated or are planning to participate in other clinical studies during the current study
(11) Subjects who are judged ineligible at the discretion of the principal investigator
10
1st name | Naoki |
Middle name | |
Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal Medicine
530-0044
9F Higashitenma building, 1-7-17 Higashitenma, Kita-ku, Osaka, Osaka
06-6135-5200
tterashima@miula.co.jp
1st name | Makoto |
Middle name | |
Last name | Terashima |
Oneness support Co., Ltd.
Clinical trial Division
530-0044
4F Higashitenma building, 1-7-17 Higashitenma, Kita-ku, Osaka, Osaka
06-4801-8917
mterashima@oneness-sup.co.jp
Morinaga & Co.,Ltd.
None
Self funding
Miura Clinic, Medical Corporation Kanonkai IRB
9F Higashitenma building, 1-7-17 Higashitenma, Kita-ku, Osaka, Osaka
06-6135-5200
tterashima@miula.co.jp
NO
医療法人花音会みうらクリニック(大阪府)
2020 | Year | 03 | Month | 09 | Day |
Published
10
Main results already published
2020 | Year | 02 | Month | 20 | Day |
2020 | Year | 02 | Month | 20 | Day |
2020 | Year | 02 | Month | 21 | Day |
2020 | Year | 06 | Month | 26 | Day |
2020 | Year | 02 | Month | 26 | Day |
2020 | Year | 11 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045172